Sorrento’s License Partner, Lee’s Pharmaceutical Announces NDA Filing Acceptance by NMPA for Anti-PD-L1 Antibody Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer

NEXT STORY
Medexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan
PREV STORY
Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Drug Apabetalone
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Promising Growth Projected for Global Medical Waste Management Market: Expected to Reach USD 9.8 Billion by 2027 | BlueWeave

author_avatar
NASDAQ Market News

Global Cell Viability Assays & Consumables Market to 2023 – Increasing Focus on Development of Cell-Based Therapeutics & Potential Biomarkers

author_avatar
NASDAQ Market News

Poultry Vaccine Market Research Report by Disease Type, by Technology, by Dosage Form – Global Forecast to 2025 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News